Biostable Double-Strand Circular Aptamers Conjugated Onto Dendrimers for Specific Capture and Inhibition of Circulating Leukemia Cells
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. 13, 13465-13477
- https://doi.org/10.2147/OTT.S287720
Abstract
Background/Objective: Circulating tumor cells (CTCs) are known as the root of cancer metastasis. Capture and inhibition of CTCs may prevent metastasis. Due to the rarity of CTCs in vivo, the current technology about CTCs capture is still challenging. The aim of our study was to conjugate the enhanced biostable double-strand (ds) circular aptamer (dApR) with dendrimers for capturing and restraining CTCs in vitro and in vivo. Methods: CEM-targeting aptamer (Ap) was looped by ligation after phosphorylation to form circular ds aptamer dApR, which was then conjugated to dendrimers by biotin-streptavidin affinity reaction and named as G-dApR. The physicochemical properties of G-dApR were characterized by using PAGE gel electrophoresis, UV, DLS, AFM, fluorophotometer and laser confocal microscope. Biostability of G-dApR was also analyzed by gel electrophoresis. Confocal microscopy and flow cytometry were then performed to determine the binding specificity of G-dApR to CEM cells and the captured CTCs in mice and in human blood. Apoptosis of the captured cells was finally evaluated by using MTT assay, DAPI staining, AO/EB staining, cell cycle analysis and Annexin V-FITC/PI staining. Results: Physicochemical characterization demonstrated the entity of dApR and G-dApR, and the nano-size of G-dApR (about 180 nm in aqueous phase). G-dApR exhibited the excellent biostability that confers their resistance to nuclease-mediated biodegradation in serum for at least 6 days. In our established CTCs model, we found that G-dApR could specifically and sensitively capture CTCs not non-target cells even in the presence of millions of interfering cells (10(8)), in mice and in human blood. Finally, the activity of captured CTCs was significantly down-regulated by G-dApR, resulting in apoptosis. Conclusion: We created the enhanced biostable dApR-coated dendrimers (G-dApR) that could specifically capture and restrain CTCs in vitro and in vivo for preventing CTC-mediated cancer metastasis.This publication has 34 references indexed in Scilit:
- Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cellsNucleic Acids Research, 2013
- Circulating Tumor Cells: Liquid Biopsy of CancerClinical Chemistry, 2013
- Aptamer-Functionalized Nanoparticles for Medical Applications: Challenges and OpportunitiesACS Nano, 2012
- Aptamer-Modified Nanodrug Delivery SystemsACS Nano, 2011
- Cancer's Circulation ProblemScience, 2010
- Carbon Nanotubes Protect DNA Strands during Cellular DeliveryACS Nano, 2008
- Aptamers evolved from live cells as effective molecular probes for cancer studyProceedings of the National Academy of Sciences of the United States of America, 2006
- Aptamer therapeutics advanceCurrent Opinion in Chemical Biology, 2006
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerThe New England Journal of Medicine, 2004
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990